Atul Pande
Director at Immunovant, Inc. (IMVT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $425K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 28SEC | IMVTImmunovant, Inc. | Sell Plan | 1,500116,731 held (−1%) | $43.27 | $65K | -29.6% |
| Jul 24SEC | IMVTImmunovant, Inc. | Sell Plan | 1,500116,731 held (−1%) | $39.80 | $60K | -23.4% |
| Jun 26SEC | IMVTImmunovant, Inc. | Sell Plan | 1,500116,731 held (−1%) | $38.01 | $57K | -19.8% |
| Jun 16SEC | IMVTImmunovant, Inc. | Sell Plan | 1,500116,731 held (−1%) | $34.02 | $51K | -10.4% |
| May 20SEC | IMVTImmunovant, Inc. | Sell Plan | 6,000116,731 held (−5%) | $32.00 | $192K | -4.8% |
- Sell
Director Atul Pande sold $65K of IMVT at $43.27 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Atul Pande sold $60K of IMVT at $39.80 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Atul Pande sold $57K of IMVT at $38.01 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Atul Pande sold $51K of IMVT at $34.02 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Atul Pande sold $192K of IMVT at $32.00 — pre-scheduled 10b5-1 plan sale.